Rankings
Pricing
Log In
Free Trial
US-listed companies
Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc.
ALRN
Market cap
$13.21M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Net loss
-
-32
-29
-21
-26
-27
Depreciation and amortization expense
0
0
0
0
0
0
Net amortization of premiums and discounts on investments
0
0
0
0
-0
0
Stock-based compensation expense
2
3
2
2
2
2
Forgiveness of Paycheck Protection Program loan
-
-
-
-
-0
-
(Gain) on disposition of property and equipment
-
-
-0
0
0
-
Prepaid expenses and other current assets
1
0
0
1
0
-2
Other assets
-
-
-1
-6
0
-
Accounts payable
-0
0
-0
0
-0
1
Operating lease liabilities
-
-
-0
-5
-0
-0
Accrued expenses and other current liabilities
1
0
0
-2
1
-2
Net cash used in operating activities
-
-28
-26
-20
-24
-25
Purchases of investments
71
31
27
10
74
22
Proceeds from sales or maturities of investments
32
60
25
16
38
48
Purchases of property and equipment
0
4
0
0
0
-
Proceeds from sale of fixed asset
-
-
-
0
0
-
Net cash (used in) provided by investing activities
-
25
-3
6
-36
26
Proceeds From Issuance Of Common Stock Common Warrants And Pre Funded Warrants Net Of Issuance Costs
-
-
24
15
56
-
Proceeds from Paycheck Protection Program Loan
-
-
-
0
-
-
Proceeds from Stock Options Exercised
0
0
0
-
0
-
Net cash provided by financing activities
-
3
24
16
56
-
Net Increase (decrease) in cash, cash equivalents and restricted cash
-
-1
-5
2
-4
2